Subscribe to Journal
Get full journal access for 1 year
only $64.85 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Hanson, M. & Gluckman, P. Developmental origins of noncommunicable disease: population and public health implications. Am. J. Clin. Nutr. 94, 1754S–1758S (2011).
Baird J. et al. Developmental origins of health and disease: a lifecourse approach to the prevention of non-communicable diseases. Healthcare 5, 14 https://doi.org/10.3390/healthcare5010014 (2017).
Adegoke, S. A. et al. Acute chest syndrome in sickle cell anaemia: higher serum levels of interleukin-8 and highly sensitive C-reactive proteins are associated with impaired lung function. Paediatr. Int. Child Health 38, 244–250 (2018).
Akinkuolie, A. O., Buring, J. E., Ridker, P. M. & Mora, S. A novel protein glycan biomarker and future cardiovascular disease events. J. Am. Heart Assoc. 3, e001221 (2014).
Ritchie, S. C. et al. The biomarker GlycA is associated with chronic inflammation and predicts long-term risk of severe infection. Cell Syst. 1, 293–301 (2015).
Fischer, K. et al. Biomarker profiling by nuclear magnetic resonance spectroscopy for the prediction of all-cause mortality: an observational study of 17,345 persons. PLoS Med. 11, e1001606 (2014).
Gruppen, E. G. et al. GlycA, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with C-reactive protein and renal function. PLoS ONE 10, e0139057 (2015).
Connelly, M. A. et al. Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children. BMC Pediatr. 16, 151 (2016).
Vuillermin, P. et al. Cohort profile: the Barwon Infant Study. Int J. Epidemiol. 44, 1148–1160 (2015).
Kianoush, S. et al. Association between smoking and serum GlycA and high-sensitivity C-reactive protein levels: the Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). J. Am. Heart Assoc. 6, e006545 (2017).
Connelly, M. A., Otvos, J. D., Shalaurova, I., Playford, M. P. & Mehta, N. N. GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk. J. Transl. Med 15, 219 (2017).
Jago, R., Drews, K. L., Otvos, J. D., Willi, S. M. & Buse, J. B. Novel measures of inflammation and insulin resistance are related to obesity and fitness in a diverse sample of 11-14 year olds: The HEALTHY Study. Int J. Obes. 40, 1157–1163 (2016).
We acknowledge the participation and commitment of the families in the Barwon Infant Study (BIS). The initial establishment work and infrastructure for the BIS was supported by the Murdoch Children’s Research Institute and Barwon Health. Deakin University is now a partner organization and has provided funding and infrastructure. Funding for this particular study was provided by the National Health and Medical Research Council of Australia (1030701).
The Barwon Investigator Group:
John Carlin - Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia.
Sarath Ranganathan - Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia.
Peter Sly - The University of Queensland, Brisbane Australia.
Mimi Tang - Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia.
Katie Allen - Murdoch Children’s Research Institute, Royal Children’s Hospital, Parkville, Australia.
Leonard C. Harrison - Walter and Eliza Hall Institute, Parkville, Australia.
Terry Dwyer - University of Oxford, Oxford, United Kingdom.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Barwon Infant Study Investigator Group
John Carlin, Sarath Ranganathan, Peter Sly, Mimi Tang, Katie Allen, Leonard C Harrison, and Terry Dwyer.
About this article
Cite this article
Collier, F., Ellul, S., Juonala, M. et al. Glycoprotein acetyls (GlycA) at 12 months are associated with high-sensitivity C-reactive protein and early life inflammatory immune measures. Pediatr Res 85, 584–585 (2019). https://doi.org/10.1038/s41390-019-0307-x
Glycoprotein A as a biomarker of pulmonary infection and inflammation in children with cystic fibrosis
Pediatric Pulmonology (2019)